305 related articles for article (PubMed ID: 17009097)
1. Adriamycin-induced oxidative mitochondrial cardiotoxicity.
Berthiaume JM; Wallace KB
Cell Biol Toxicol; 2007 Jan; 23(1):15-25. PubMed ID: 17009097
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis.
Wallace KB
Cardiovasc Toxicol; 2007; 7(2):101-7. PubMed ID: 17652813
[TBL] [Abstract][Full Text] [Related]
3. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.
Kim DS; Woo ER; Chae SW; Ha KC; Lee GH; Hong ST; Kwon DY; Kim MS; Jung YK; Kim HM; Kim HK; Kim HR; Chae HJ
Life Sci; 2007 Jan; 80(4):314-23. PubMed ID: 17034819
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain.
Tangpong J; Cole MP; Sultana R; Estus S; Vore M; St Clair W; Ratanachaiyavong S; St Clair DK; Butterfield DA
J Neurochem; 2007 Jan; 100(1):191-201. PubMed ID: 17227439
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline degradation in cardiomyocytes: a journey to oxidative survival.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2010 Jan; 23(1):6-10. PubMed ID: 19954191
[TBL] [Abstract][Full Text] [Related]
6. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
7. Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice.
Chen Y; Daosukho C; Opii WO; Turner DM; Pierce WM; Klein JB; Vore M; Butterfield DA; St Clair DK
Free Radic Biol Med; 2006 Nov; 41(9):1470-7. PubMed ID: 17023274
[TBL] [Abstract][Full Text] [Related]
8. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction.
Oliveira PJ; Wallace KB
Toxicology; 2006 Mar; 220(2-3):160-8. PubMed ID: 16427179
[TBL] [Abstract][Full Text] [Related]
9. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain.
Joshi G; Hardas S; Sultana R; St Clair DK; Vore M; Butterfield DA
J Neurosci Res; 2007 Feb; 85(3):497-503. PubMed ID: 17171703
[TBL] [Abstract][Full Text] [Related]
10. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
Berthiaume JM; Wallace KB
Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
[TBL] [Abstract][Full Text] [Related]
11. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
De Graff WG; Myers LS; Mitchell JB; Hahn SM
Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
[TBL] [Abstract][Full Text] [Related]
12. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice.
Yen HC; Oberley TD; Gairola CG; Szweda LI; St Clair DK
Arch Biochem Biophys; 1999 Feb; 362(1):59-66. PubMed ID: 9917329
[TBL] [Abstract][Full Text] [Related]
13. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
14. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain.
Joshi G; Sultana R; Tangpong J; Cole MP; St Clair DK; Vore M; Estus S; Butterfield DA
Free Radic Res; 2005 Nov; 39(11):1147-54. PubMed ID: 16298740
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-specific nano-emulsified therapy for myocardial protection against doxorubicin-induced cardiotoxicity.
Faulk A; Weissig V; Elbayoumi T
Methods Mol Biol; 2013; 991():99-112. PubMed ID: 23546663
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue.
Montali U; Del Tacca M; Bernardini C; Segnini D; Solaini G
Drugs Exp Clin Res; 1985; 11(3):219-22. PubMed ID: 3836126
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity.
Alyane M; Kebsa LB; Boussenane H; Rouibah H; Lahouel M
Pak J Pharm Sci; 2008 Jul; 21(3):201-9. PubMed ID: 18614413
[TBL] [Abstract][Full Text] [Related]
19. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats.
Othman AI; El-Missiry MA; Amer MA; Arafa M
Life Sci; 2008 Oct; 83(15-16):563-8. PubMed ID: 18793653
[TBL] [Abstract][Full Text] [Related]
20. alpha-Tocopherol, MDA-HNE and 8-OHdG levels in liver and heart mitochondria of adriamycin-treated rats fed with alcohol-free beer.
Valls-Belles V; Torres Mdel C; Boix L; Muñiz P; Gonzalez-Sanjose ML; Codoñer-Franch P
Toxicology; 2008 Jul; 249(2-3):97-101. PubMed ID: 18513847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
